Evidence map›Paper›PMID 31930061›Full record

ArticleAnnals of translational medicine2019

Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study.

Ying Su, Min-Jie Ju, Jie-Fei Ma, Guo-Wei Tu, Hong-Yu He, Zhun-Yong Gu, Yuan-Lin Song, Jing Zhang, Zhe Luo

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Association of lactate dehydrogenase with mortality in incident hemodialysis patients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ying SuDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Min-Jie JuDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jie-Fei MaDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Guo-Wei TuDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Hong-Yu HeDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhun-Yong GuDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yuan-Lin SongDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jing ZhangDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhe LuoDepartment of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
The First Affiliated Hospital, Sun Yat-sen University · CNZhongshan Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLactate dehydrogenase (LDH) is an easily accessible biological marker that has been associated with several pulmonary disorders. The aim of this study was to investigate the prognostic value of serum LDH in renal transplant recipients with severe community-acquired pneumonia (CAP).

methodsA total of 77 renal transplant recipients with severe CAP admitted to the intensive care unit (ICU) were screened for eligibility in this retrospective study. Patient characteristics and laboratory tests, such as LDH on day 1 (LDH

resultsMedian LDH level was higher on day 1 in 90-day nonsurvivors (440 U/L, IQR, 362-1,055 U/L) than in survivors (334 U/L, IQR, 265-432 U/L; P<0.001); median LDH level on day 3 in nonsurvivors was 522.5 U/L (IQR, 457.5-1,058.5 U/L) and in survivors 290 U/L (IQR, 223-387.5 U/L; P<0.001). Analysis of LDH kinetics from day 1 to day 3 showed an increase in nonsurvivors and a decrease in survivors. Moreover, Multivariate Cox analysis showed that LDH

conclusionsSerum LDH levels and LDH kinetics early were independently associated with 90-day mortality in renal transplant recipients with severe CAP. In future, the prognostic role of LDH needs to be warranted.

Indexed as

Community-acquired pneumonia (CAP)lactate dehydrogenase (LDH)mortalityrenal transplantationsevere pneumonia

Identifiers

PMID31930061
PMCPMC6944597
OpenAlexW2985965720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.